Epilepsy patients have the promise of new treatment options
Positive clinical trial results from Xenon Pharmaceuticals could lead to a breakthrough treatment for epilepsy.
Introducing Professor Julian Gillmore
Professor Gillmore is distinguished for his expertise in the field of amyloidosis and has extensive experience in the development, diagnosis and treatment of this disease.
What you can expect when taking part in a clinical trial
It’s important that our volunteers have a great experience with us from start to finish. Here we outline what you can expect from your initial point of contact to the end of your participation and beyond.
Meet Giuseppe Rosano
We are delighted to name Giuseppe Rosano, MD, PhD, as an active collaborator on the chronic heart failure studies we conduct at Richmond Pharmacology